Institute of Oncology Research (IOR)
@iorbellinzona.bsky.social
8 Research groups
120+ Staff members
750+ Issued publications
60+ Awarded PhD degrees
www.ior.usi.ch
Based in Bellinzona (Switzerland), IOR is affiliated to @usi.ch and member of Bios+ (www.biosplus.ch).
120+ Staff members
750+ Issued publications
60+ Awarded PhD degrees
www.ior.usi.ch
Based in Bellinzona (Switzerland), IOR is affiliated to @usi.ch and member of Bios+ (www.biosplus.ch).
Pinned
IOR&IOSI for #Movember
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
#IORnews
Major awards to IOR and IOSI at SOHC 2025 in Basel.
Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions.
Read more: ior.usi.ch/events-news/...
Major awards to IOR and IOSI at SOHC 2025 in Basel.
Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions.
Read more: ior.usi.ch/events-news/...
November 25, 2025 at 1:22 PM
#IORnews
Major awards to IOR and IOSI at SOHC 2025 in Basel.
Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions.
Read more: ior.usi.ch/events-news/...
Major awards to IOR and IOSI at SOHC 2025 in Basel.
Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions.
Read more: ior.usi.ch/events-news/...
#IORnews
🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant!
🔗https://shorturl.at/BnMjx
🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant!
🔗https://shorturl.at/BnMjx
November 18, 2025 at 8:24 AM
#IORnews
🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant!
🔗https://shorturl.at/BnMjx
🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant!
🔗https://shorturl.at/BnMjx
⏳ One month left to submit your abstracts for the International Prostate Cancer Symposium 2026!
Don’t miss the December 12, 2025 deadline to submit your work for IPCS 2026.
This is a great opportunity to showcase your research to leading experts shaping the future of prostate cancer care ⬇️
Don’t miss the December 12, 2025 deadline to submit your work for IPCS 2026.
This is a great opportunity to showcase your research to leading experts shaping the future of prostate cancer care ⬇️
November 13, 2025 at 8:54 AM
⏳ One month left to submit your abstracts for the International Prostate Cancer Symposium 2026!
Don’t miss the December 12, 2025 deadline to submit your work for IPCS 2026.
This is a great opportunity to showcase your research to leading experts shaping the future of prostate cancer care ⬇️
Don’t miss the December 12, 2025 deadline to submit your work for IPCS 2026.
This is a great opportunity to showcase your research to leading experts shaping the future of prostate cancer care ⬇️
#IORnews
On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration.
Read more: ior.usi.ch/events-news/...
On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration.
Read more: ior.usi.ch/events-news/...
November 12, 2025 at 2:19 PM
#IORnews
On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration.
Read more: ior.usi.ch/events-news/...
On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration.
Read more: ior.usi.ch/events-news/...
IOR&IOSI for #Movember
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
November 11, 2025 at 10:34 AM
IOR&IOSI for #Movember
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
Many of our researchers dedicate their work to understanding & treating #prostatecancer. This effort is strengthened by our long-standing partnership with IOSI, which has led to exciting discoveries from the lab to the clinic.
Don’t forget to get checked - prevention matters.
#IORnews
🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant!
This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases.
🔗 shorturl.at/ghhNJ
🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant!
This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases.
🔗 shorturl.at/ghhNJ
November 11, 2025 at 9:34 AM
#IORnews
🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant!
This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases.
🔗 shorturl.at/ghhNJ
🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant!
This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases.
🔗 shorturl.at/ghhNJ
#IORnews
🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
November 6, 2025 at 8:30 AM
#IORnews
🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
#IORmoments
Today we were delighted to host Prof. Dr. Zoran Culig from the Medical University of Innsbruck for his lecture on “Androgen receptor coactivators in advanced prostate cancer” in our PhD Lecture Series.
Thank you for such an inspiring talk!
Today we were delighted to host Prof. Dr. Zoran Culig from the Medical University of Innsbruck for his lecture on “Androgen receptor coactivators in advanced prostate cancer” in our PhD Lecture Series.
Thank you for such an inspiring talk!
October 31, 2025 at 3:03 PM
#IORmoments
Today we were delighted to host Prof. Dr. Zoran Culig from the Medical University of Innsbruck for his lecture on “Androgen receptor coactivators in advanced prostate cancer” in our PhD Lecture Series.
Thank you for such an inspiring talk!
Today we were delighted to host Prof. Dr. Zoran Culig from the Medical University of Innsbruck for his lecture on “Androgen receptor coactivators in advanced prostate cancer” in our PhD Lecture Series.
Thank you for such an inspiring talk!
#IORnews
Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences.
🔗 ior.usi.ch/events-news/...
Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences.
🔗 ior.usi.ch/events-news/...
October 24, 2025 at 1:13 PM
#IORnews
Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences.
🔗 ior.usi.ch/events-news/...
Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences.
🔗 ior.usi.ch/events-news/...
#IORnews
IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer.
➡️ Learn more: ior.usi.ch/events-news/...
IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer.
➡️ Learn more: ior.usi.ch/events-news/...
October 23, 2025 at 8:42 AM
#IORnews
IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer.
➡️ Learn more: ior.usi.ch/events-news/...
IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer.
➡️ Learn more: ior.usi.ch/events-news/...
#IORnews
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
October 16, 2025 at 11:44 AM
#IORnews
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
#PinkOctober
🎀 October is Breast Cancer Awareness Month
At IOR, we stand at the forefront of the fight against breast cancer. Our Cancer Immunotherapy Lab studies how cancer cells interact with bacteria and the immune system to develop new therapies.
Let’s raise awareness - prevention saves lives.
🎀 October is Breast Cancer Awareness Month
At IOR, we stand at the forefront of the fight against breast cancer. Our Cancer Immunotherapy Lab studies how cancer cells interact with bacteria and the immune system to develop new therapies.
Let’s raise awareness - prevention saves lives.
October 15, 2025 at 8:50 AM
#PinkOctober
🎀 October is Breast Cancer Awareness Month
At IOR, we stand at the forefront of the fight against breast cancer. Our Cancer Immunotherapy Lab studies how cancer cells interact with bacteria and the immune system to develop new therapies.
Let’s raise awareness - prevention saves lives.
🎀 October is Breast Cancer Awareness Month
At IOR, we stand at the forefront of the fight against breast cancer. Our Cancer Immunotherapy Lab studies how cancer cells interact with bacteria and the immune system to develop new therapies.
Let’s raise awareness - prevention saves lives.
We had the honor to host Dr. Taewan Kim (DIGIT, South Korea) for a special seminar at IOR. He is renowned for pioneering Parkinson’s disease modeling using human pluripotent stem cells. Thank you for the inspiring talk!
October 13, 2025 at 6:52 AM
We had the honor to host Dr. Taewan Kim (DIGIT, South Korea) for a special seminar at IOR. He is renowned for pioneering Parkinson’s disease modeling using human pluripotent stem cells. Thank you for the inspiring talk!
#IORjobs
Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini:
- PhD Student: ior.usi.ch/events-news/...
- Lab Technician: ior.usi.ch/events-news/...
Apply now and join Baggiolini’s international and inspiring team!
Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini:
- PhD Student: ior.usi.ch/events-news/...
- Lab Technician: ior.usi.ch/events-news/...
Apply now and join Baggiolini’s international and inspiring team!
October 2, 2025 at 7:40 AM
#IORjobs
Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini:
- PhD Student: ior.usi.ch/events-news/...
- Lab Technician: ior.usi.ch/events-news/...
Apply now and join Baggiolini’s international and inspiring team!
Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini:
- PhD Student: ior.usi.ch/events-news/...
- Lab Technician: ior.usi.ch/events-news/...
Apply now and join Baggiolini’s international and inspiring team!
#IORmoments
Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie!
We truly appreciated his time and the stimulating discussion with our community.
Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie!
We truly appreciated his time and the stimulating discussion with our community.
September 26, 2025 at 1:33 PM
#IORmoments
Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie!
We truly appreciated his time and the stimulating discussion with our community.
Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie!
We truly appreciated his time and the stimulating discussion with our community.
#IORnews
IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies.
🔗Learn more: ior.usi.ch/events-news/...
IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies.
🔗Learn more: ior.usi.ch/events-news/...
September 19, 2025 at 12:34 PM
#IORnews
IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies.
🔗Learn more: ior.usi.ch/events-news/...
IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies.
🔗Learn more: ior.usi.ch/events-news/...
🌐 The IOR Foundation has a brand-new website!
Discover more about our Foundation, which manages:
- our Institute, the IOR
- The International Extranodal Lymphoma Study Group (IELSG)
- The International Conference on Malignant Lymphoma (ICML)
🔗 www.foundationior.ch
Discover more about our Foundation, which manages:
- our Institute, the IOR
- The International Extranodal Lymphoma Study Group (IELSG)
- The International Conference on Malignant Lymphoma (ICML)
🔗 www.foundationior.ch
September 17, 2025 at 8:04 AM
🌐 The IOR Foundation has a brand-new website!
Discover more about our Foundation, which manages:
- our Institute, the IOR
- The International Extranodal Lymphoma Study Group (IELSG)
- The International Conference on Malignant Lymphoma (ICML)
🔗 www.foundationior.ch
Discover more about our Foundation, which manages:
- our Institute, the IOR
- The International Extranodal Lymphoma Study Group (IELSG)
- The International Conference on Malignant Lymphoma (ICML)
🔗 www.foundationior.ch
#IORnews
The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility.
🔗 short-url.org/1ecu9
www.youtube.com/watch?v=qTjJ...
The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility.
🔗 short-url.org/1ecu9
www.youtube.com/watch?v=qTjJ...
Prostate Cancer Atlas
YouTube video by Prostate Cancer Atlas
www.youtube.com
September 12, 2025 at 10:36 AM
#IORnews
The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility.
🔗 short-url.org/1ecu9
www.youtube.com/watch?v=qTjJ...
The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility.
🔗 short-url.org/1ecu9
www.youtube.com/watch?v=qTjJ...
#IORnews
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
September 9, 2025 at 8:26 AM
#IORnews
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
#IORnews
The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies.
🔗Read more: ior.usi.ch/events-news/...
@calcinottolab.bsky.social
The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies.
🔗Read more: ior.usi.ch/events-news/...
@calcinottolab.bsky.social
August 19, 2025 at 12:21 PM
#IORnews
The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies.
🔗Read more: ior.usi.ch/events-news/...
@calcinottolab.bsky.social
The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies.
🔗Read more: ior.usi.ch/events-news/...
@calcinottolab.bsky.social
#IORnews
Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement.
Read more: shorturl.at/pLKnm
Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement.
Read more: shorturl.at/pLKnm
August 7, 2025 at 8:38 AM
#IORnews
Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement.
Read more: shorturl.at/pLKnm
Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement.
Read more: shorturl.at/pLKnm
#IORnews
Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer.
Read more: shorturl.at/xqmAd
Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer.
Read more: shorturl.at/xqmAd
July 18, 2025 at 2:07 PM
#IORnews
Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer.
Read more: shorturl.at/xqmAd
Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer.
Read more: shorturl.at/xqmAd
Registration is open for the International Prostate Cancer Symposium (IPCS) 28–29 April 2026 – Lugano, Switzerland
Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care.
🔗Register now: apccc.org
Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care.
🔗Register now: apccc.org
July 5, 2025 at 10:08 AM
Registration is open for the International Prostate Cancer Symposium (IPCS) 28–29 April 2026 – Lugano, Switzerland
Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care.
🔗Register now: apccc.org
Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care.
🔗Register now: apccc.org
#IORjobs
IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships.
⏳ IOR internal deadline: 3 August 2025
➡️ Details & application procedure: shorturl.at/caVdu
IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships.
⏳ IOR internal deadline: 3 August 2025
➡️ Details & application procedure: shorturl.at/caVdu
July 4, 2025 at 2:10 PM
#IORjobs
IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships.
⏳ IOR internal deadline: 3 August 2025
➡️ Details & application procedure: shorturl.at/caVdu
IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships.
⏳ IOR internal deadline: 3 August 2025
➡️ Details & application procedure: shorturl.at/caVdu
#IORnews
New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness.
🔗 Read the news: shorturl.at/wZWou
New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness.
🔗 Read the news: shorturl.at/wZWou
July 3, 2025 at 8:07 AM
#IORnews
New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness.
🔗 Read the news: shorturl.at/wZWou
New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness.
🔗 Read the news: shorturl.at/wZWou